Apr 29, 2024 | Uncategorized
Researchers at the University of Michigan Health Rogel Cancer Center have made a significant breakthrough in cancer detection with the development of a urine-based test. This innovative test detects DNA fragments shed by head and neck tumors, offering a non-invasive...
Apr 28, 2024 | Uncategorized
In a groundbreaking analysis, an international collaboration of researchers has uncovered 50 novel genomic regions associated with the risk of kidney cancer development. Led by scientists at the National Cancer Institute (NCI), part of the National Institutes of...
Apr 22, 2024 | Uncategorized
In recent years, the integration of computed tomography (CT) coronary artery calcium (CAC) testing has surged following the 2018 ACC/AHA Cholesterol Guideline recommendation. This low-cost screening tool, typically priced between $50-$150, has become a pivotal...
Apr 22, 2024 | Uncategorized
The American Heart Association (AHA) recently unveiled its latest risk assessment tool, PREVENT (Predicting Risk of cardiovascular disease EVENTs), aiming to evaluate heart attack, stroke, and heart failure risks. While the tool incorporates established risk factors,...
Apr 22, 2024 | Uncategorized
A groundbreaking combination therapy involving adagrasib (Krazati) alongside cetuximab (Erbitux) has demonstrated substantial efficacy and tolerability in individuals with advanced or metastatic colorectal cancer (mCRC) carrying KRAS G12C mutations. These encouraging...
Apr 21, 2024 | Uncategorized
In recent years, the utilization of whole-genome sequencing (WGS) in precision oncology has experienced a notable upsurge. Initially established for rare and pediatric diseases, WGS has now gained traction in clinical labs for cancer diagnostics. Advantages of...
